Assessment of radiation protection awareness levels in medical radiation science technologists - a pilot survey

To assess the radiation protection awareness levels of medical radiation technologists working in three major hospitals of Peshawar metropolitan. Material and The authors developed two questionnaires along with curriculum vitae form for the radiographers and radiation technologists. The questionnaires contained questions pertaining to radiation protection practices, procedures, dose limits and existing national and international standards They were asked to complete the questionnaires and the same were collected back on the spot. Forty one technologists were included in this pilot survey. The educational qualification of the 41 technologists in all the three specialities ranged from secondary school certificate to Master of Arts. The experience duration [mean +/- SD] of the sample group professional practice in medical radiation science [MRS] technology was 15 +/- 8 years, with duration ranging from 1-32 years. It was observed that the radiation awareness knowledge levels in the sample group varied widely with a range of 35-95% and a median score of 75%. It was observed that educational background and duration of experience in the medical radiation science profession affects the awareness levels. The survey results revealed that there is a strong need for technologists training programme in all the three MRS specialities both at regional and national level. Moreover there is also a need for relevant educational background in science and introduction of personal qualities [PQA] tests for MRS technologists at the time of selection and recruitments

Recurrent rectal carcinoma treated with high dose rate intraluminal brachy therapy

A 65 years old man with recurrent rectal cancer was treated with remote afterloading High Dose Rate Intraluminal Brachytherapy [HDRILB]. After eight weeks of HDRILB there was complete regression of the tumor. Bleeding per rectum and pain in the perineum were greatly improved. He died of myocardial infarction after 41 months of treatment with HDRILB. The treated lesions were incomplete remission at the time of death. The procedure was well tolerated. The only treatment-associated toxicity was grade 2 proctitis, which was treated conservatively. HDRILB can be used as one of the treatment options in patients with recurrent rectal cancers who have undergone previous abdominal surgery and external beam irradiation, as exhibited in our limited experience